Editors: Claudia Kuntner-Hannes, York Haemisch

2019

In the last decade, our understanding of the function of the human body and the interaction of drugs with certain molecular targets has increased significantly. This deepened insight is a result of the wider availability of new diagnostic tools such as those developed by the different “-omics” disciplines (genomics, proteomics, etc.), but largely also of the application of noninvasive, in vivo imaging techniques applying molecular targets and markers.